Neuro-oncology
Feature
What causes cancer? There’s a lot we don’t know
Obesity status over time may be more relevant to cancer risk than one-off measures.
Conference Coverage
‘Remarkable’ results for targeted therapy of rare CNS tumors
Conference Coverage
CAR-T in children branching out to solid tumors
From the Journals
Neurologic disorders ubiquitous and rising in the U.S.
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level...
From the Journals
Detailed glioblastoma map could lead to better treatment approaches
From the Journals
Genomic analysis reveals insights into pathogenesis of neuroblastoma
Researchers identified drivers of disease and potential therapeutic targets.
Conference Coverage
Evaluating the impact of new pediatric brain tumor classifications
Additional molecular subtypes of childhood brain tumors will have far-reaching implications for diagnosis and management.
From the Journals
Subgroups predict adjuvant chemoradiotherapy benefits in low-grade glioma
From the Journals
Glioma trials should track living well, not just longer
“Patients want to live longer, but they also want to continue to function as well as possible for as long as possible,“ said Terri S. Armstrong,...
From the Journals
QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolide
Adding lomustine to temozolomide did not decrease quality of life for patients, apart from clinically insignificant differences in mental function...
Latest News
Researchers seek a way to predict cognitive deficits in children treated for ALL
Researchers are investigating gene variants and biomarkers that might correlate with chemotherapy-induced cognitive deficits.